STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy
T. L. Sheehy, A. J. Kwiatkowski, K. Arora, B. R. Kimmel, J. A. Schulman, K. Gibson-Corley, J. T. Wilson
This paper develops SAPCon, a polymer-drug conjugate that activates the STING pathway in tumors, enhancing immunotherapy efficacy by promoting an immunogenic microenvironment and improving tumor growth inhibition.
bioRxiv · Mar 23, 2024Bioengineering